<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36891312</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>MicroRNA-183/96/182 cluster in immunity and autoimmunity.</ArticleTitle><Pagination><StartPage>1134634</StartPage><MedlinePgn>1134634</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1134634</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1134634</ELocationID><Abstract><AbstractText>MicroRNAs (miRNAs) are crucial post-transcriptional regulators of gene expression in ubiquitous biological processes, including immune-related pathways. This review focuses on the miR-183/96/182 cluster (miR-183C), which contains three miRNAs, miR-183, -96, and -182, having almost identical seed sequences with minor differences. The similarity among seed sequences allows these three miRNAs to act cooperatively. In addition, their minor differences permit them to target distinct genes and regulate unique pathways. The expression of miR-183C was initially identified in sensory organs. Subsequently, abnormal expression of miR-183C miRNAs in various cancers and autoimmune diseases has been reported, implying their potential role in human diseases. The regulatory effects of miR-183C miRNAs on the differentiation and function of both innate and adaptive immune cells have now been documented. In this review, we have discussed the complex role of miR-183C in the immune cells in both normal and autoimmune backgrounds. We highlighted the dysregulation of miR-183C miRNAs in several autoimmune diseases, including systemic lupus erythematosus (SLE), multiple sclerosis (MS), and ocular autoimmune disorders, and discussed the potential for utilizing miR-183C as biomarkers and therapeutic targets of specific autoimmune diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Wang, Dai and Ahmed.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhuang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine (VMCVM), Virginia Tech, Blacksburg, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Rujuan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine (VMCVM), Virginia Tech, Blacksburg, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Sattar Ansar</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine (VMCVM), Virginia Tech, Blacksburg, VA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C533449">MIRN183 microRNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune</Keyword><Keyword MajorTopicYN="N">autoinflammatory diseases</Keyword><Keyword MajorTopicYN="N">epigenetic regulation</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">miR-183/96/182 cluster</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>2</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36891312</ArticleId><ArticleId IdType="pmc">PMC9986322</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1134634</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bartel DP. Micrornas: Genomics, biogenesis, mechanism, and function. Cell (2004) 116(2):281&#x2013;97. doi:&#xa0;10.1016S0092-8674(04)00045-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microrna biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) (2018) 9:402. doi:&#xa0;10.3389/fendo.2018.00402</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00402</ArticleId><ArticleId IdType="pmc">PMC6085463</ArticleId><ArticleId IdType="pubmed">30123182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee RC, Feinbaum RL, Ambros V. The c. elegans heterochronic gene Lin-4 encodes small rnas with antisense complementarity to Lin-14. Cell (1993) 75(5):843&#x2013;54. doi:&#xa0;10.1016/0092-8674(93)90529-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90529-y</ArticleId><ArticleId IdType="pubmed">8252621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene Lin-14 by Lin-4 mediates temporal pattern formation in c. elegans. Cell (1993) 75(5):855&#x2013;62. doi:&#xa0;10.1016/0092-8674(93)90530-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90530-4</ArticleId><ArticleId IdType="pubmed">8252622</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardin SE, Borchert GM. Viral micrornas, host micrornas regulating viruses, and bacterial microrna-like rnas. Methods Mol Biol (2017) 1617:39&#x2013;56. doi:&#xa0;10.1007/978-1-4939-7046-9_3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7046-9_3</ArticleId><ArticleId IdType="pubmed">28540675</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones-Rhoades MW, Bartel DP, Bartel B. Micrornas and their regulatory roles in plants. Annu Rev Plant Biol (2006) 57:19&#x2013;53. doi:&#xa0;10.1146/annurev.arplant.57.032905.105218</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.arplant.57.032905.105218</ArticleId><ArticleId IdType="pubmed">16669754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. Metazoan micrornas. Cell (2018) 173(1):20&#x2013;51. doi:&#xa0;10.1016/j.cell.2018.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozomara A, Birgaoanu M, Griffiths-Jones S. Mirbase: From microrna sequences to function. Nucleic Acids Res (2019) 47(D1):D155&#x2013;D62. doi:&#xa0;10.1093/nar/gky1141</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1141</ArticleId><ArticleId IdType="pmc">PMC6323917</ArticleId><ArticleId IdType="pubmed">30423142</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mrnas are conserved targets of micrornas. Genome Res (2009) 19(1):92&#x2013;105. doi:&#xa0;10.1101/gr.082701.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.082701.108</ArticleId><ArticleId IdType="pmc">PMC2612969</ArticleId><ArticleId IdType="pubmed">18955434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell (2005) 120(1):15&#x2013;20. doi: 10.1016/j.cell.2004.12.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.12.035</ArticleId><ArticleId IdType="pubmed">15652477</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh J. Molecular network analysis of human microrna targetome: From cancers to alzheimer's disease. BioData Min (2012) 5(1):17. doi:&#xa0;10.1186/1756-0381-5-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0381-5-17</ArticleId><ArticleId IdType="pmc">PMC3492042</ArticleId><ArticleId IdType="pubmed">23034144</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. Micrornas: New regulators of immune cell development and function. Nat Immunol (2008) 9(8):839&#x2013;45. doi:&#xa0;10.1038/ni.f.209</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.f.209</ArticleId><ArticleId IdType="pubmed">18645592</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidigal JA, Ventura A. The biological functions of mirnas: Lessons from in vivo studies. Trends Cell Biol (2015) 25(3):137&#x2013;47. doi:&#xa0;10.1016/j.tcb.2014.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2014.11.004</ArticleId><ArticleId IdType="pmc">PMC4344861</ArticleId><ArticleId IdType="pubmed">25484347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Q, Zhang L, Pearce WJ. Micrornas in brain development and cerebrovascular pathophysiology. Am J Physiol Cell Physiol (2019) 317(1):C3&#x2013;C19. doi:&#xa0;10.1152/ajpcell.00022.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00022.2019</ArticleId><ArticleId IdType="pmc">PMC6689752</ArticleId><ArticleId IdType="pubmed">30840494</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVeale B, Swindlehurst-Chan J, Blelloch R. The roles of micrornas in mouse development. Nat Rev Genet (2021) 22(5):307&#x2013;23. doi:&#xa0;10.1038/s41576-020-00309-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-020-00309-5</ArticleId><ArticleId IdType="pubmed">33452500</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwivedi S, Purohit P, Sharma P. Micrornas and diseases: Promising biomarkers for diagnosis and therapeutics. Indian J Clin Biochem (2019) 34(3):243&#x2013;5. doi:&#xa0;10.1007/s12291-019-00844-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12291-019-00844-x</ArticleId><ArticleId IdType="pmc">PMC6660526</ArticleId><ArticleId IdType="pubmed">31391712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupaimoole R, Slack FJ. Microrna therapeutics: Towards a new era for the management of cancer and other diseases. Nat Rev Drug Discovery (2017) 16(3):203&#x2013;22. doi:&#xa0;10.1038/nrd.2016.246</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2016.246</ArticleId><ArticleId IdType="pubmed">28209991</ArticleId></ArticleIdList></Reference><Reference><Citation>Evangelatos G, Fragoulis GE, Koulouri V, Lambrou GI. Micrornas in rheumatoid arthritis: From pathogenesis to clinical impact. Autoimmun Rev (2019) 18(11):102391. doi:&#xa0;10.1016/j.autrev.2019.102391</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.102391</ArticleId><ArticleId IdType="pubmed">31520804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R, Ahmed SA. Microrna, an important epigenetic regulator of immunity and autoimmunity. In: Laurence J, editor. Translating micrornas to the clinic. ELSEVIER; (2016) 223&#x2013;58. doi:&#xa0;10.1016/B978-0-12-800553-8.00009-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-800553-8.00009-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Witmer PD, Lumayag S, Kovacs B, Valle D. Microrna (Mirna) transcriptome of mouse retina and identification of a sensory organ-specific mirna cluster. J Biol Chem (2007) 282(34):25053&#x2013;66. doi:&#xa0;10.1074/jbc.M700501200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M700501200</ArticleId><ArticleId IdType="pubmed">17597072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L, et al. . Mirnps: A novel class of ribonucleoproteins containing numerous micrornas. Genes Dev (2002) 16(6):720&#x2013;8. doi:&#xa0;10.1101/gad.974702</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.974702</ArticleId><ArticleId IdType="pmc">PMC155365</ArticleId><ArticleId IdType="pubmed">11914277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. Vertebrate microrna genes. Science (2003) 299(5612):1540. doi:&#xa0;10.1126/science.1080372</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1080372</ArticleId><ArticleId IdType="pubmed">12624257</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T. New micrornas from mouse and human. RNA (2003) 9(2):175&#x2013;9. doi:&#xa0;10.1261/rna.2146903</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2146903</ArticleId><ArticleId IdType="pmc">PMC1370382</ArticleId><ArticleId IdType="pubmed">12554859</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks SA, Pierce ML, Soukup GA. Sensational micrornas: Neurosensory roles of the microrna-183 family. Mol Neurobiol (2020) 57(1):358&#x2013;71. doi:&#xa0;10.1007/s12035-019-01717-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01717-3</ArticleId><ArticleId IdType="pubmed">31359323</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Zhang L, Wang J, Huang Z, Li X, Wu M, et al. . High expression of microrna-183/182/96 cluster as a prognostic biomarker for breast cancer. Sci Rep (2016) 6:24502. doi:&#xa0;10.1038/srep24502</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24502</ArticleId><ArticleId IdType="pmc">PMC4829912</ArticleId><ArticleId IdType="pubmed">27071841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang QH, Sun HM, Zheng RZ, Li YC, Zhang Q, Cheng P, et al. . Meta-analysis of microrna-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Gene (2013) 527(1):26&#x2013;32. doi:&#xa0;10.1016/j.gene.2013.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2013.06.006</ArticleId><ArticleId IdType="pubmed">23791657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan C, Bi W, Lin P, Zhang Y, Tian J, Fang S, et al. . Microrna 182 promotes T helper 1 cell by repressing hypoxia induced factor 1 alpha in experimental autoimmune encephalomyelitis. Eur J Immunol (2019) 49(12):2184&#x2013;94. doi:&#xa0;10.1002/eji.201948111</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201948111</ArticleId><ArticleId IdType="pubmed">31411745</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai R, Zhang Y, Khan D, Heid B, Caudell D, Crasta O, et al. . Identification of a common lupus disease-associated microrna expression pattern in three different murine models of lupus. PloS One (2010) 5(12):e14302. doi:&#xa0;10.1371/journal.pone.0014302</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014302</ArticleId><ArticleId IdType="pmc">PMC3000827</ArticleId><ArticleId IdType="pubmed">21170274</ArticleId></ArticleIdList></Reference><Reference><Citation>Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M, Khankhanian P, et al. . Differential micro rna expression in pbmc from multiple sclerosis patients. PloS One (2009) 4(7):e6309. doi:&#xa0;10.1371/journal.pone.0006309</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0006309</ArticleId><ArticleId IdType="pmc">PMC2708922</ArticleId><ArticleId IdType="pubmed">19617918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Liang AJ, Fan YP, Huang YR, Zhao XM, Sun Y, et al. . Dysregulation and functional roles of mir-183-96-182 cluster in cancer cell proliferation, invasion and metastasis. Oncotarget (2016) 7(27):42805&#x2013;25. doi:&#xa0;10.18632/oncotarget.8715</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.8715</ArticleId><ArticleId IdType="pmc">PMC5173173</ArticleId><ArticleId IdType="pubmed">27081087</ArticleId></ArticleIdList></Reference><Reference><Citation>Dambal S, Shah M, Mihelich B, Nonn L. The microrna-183 cluster: The family that plays together stays together. Nucleic Acids Res (2015) 43(15):7173&#x2013;88. doi:&#xa0;10.1093/nar/gkv703</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv703</ArticleId><ArticleId IdType="pmc">PMC4551935</ArticleId><ArticleId IdType="pubmed">26170234</ArticleId></ArticleIdList></Reference><Reference><Citation>Stittrich AB, Haftmann C, Sgouroudis E, Kuhl AA, Hegazy AN, Panse I, et al. . The microrna mir-182 is induced by il-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol (2010) 11(11):1057&#x2013;62. doi:&#xa0;10.1038/ni.1945</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1945</ArticleId><ArticleId IdType="pubmed">20935646</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichiyama K, Gonzalez-Martin A, Kim BS, Jin HY, Jin W, Xu W, et al. . The microrna-183-96-182 cluster promotes T helper 17 cell pathogenicity by negatively regulating transcription factor Foxo1 expression. Immunity (2016) 44(6):1284&#x2013;98. doi:&#xa0;10.1016/j.immuni.2016.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.05.015</ArticleId><ArticleId IdType="pmc">PMC4918454</ArticleId><ArticleId IdType="pubmed">27332731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Heid B, Lu R, Sachdeva M, Edwards MR, Ren J, et al. . Deletion of microrna-183-96-182 cluster in lymphocytes suppresses anti-dsdna autoantibody production and igg deposition in the kidneys in C57bl/6-Fas(Lpr/Lpr) mice. Front Genet (2022) 13:840060. doi:&#xa0;10.3389/fgene.2022.840060</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.840060</ArticleId><ArticleId IdType="pmc">PMC9301314</ArticleId><ArticleId IdType="pubmed">35873462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichiyama K, Dong C. The role of mir-183 cluster in immunity. Cancer Lett (2019) 443:108&#x2013;14. doi:&#xa0;10.1016/j.canlet.2018.11.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2018.11.035</ArticleId><ArticleId IdType="pubmed">30529154</ArticleId></ArticleIdList></Reference><Reference><Citation>Weston MD, Pierce ML, Rocha-Sanchez S, Beisel KW, Soukup GA. Microrna gene expression in the mouse inner ear. Brain Res (2006) 1111(1):95&#x2013;104. doi:&#xa0;10.1016/j.brainres.2006.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2006.07.006</ArticleId><ArticleId IdType="pubmed">16904081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MA, Quint E, Glazier AM, Fuchs H, De Angelis MH, Langford C, et al. . An enu-induced mutation of mir-96 associated with progressive hearing loss in mice. Nat Genet (2009) 41(5):614&#x2013;8. doi:&#xa0;10.1038/ng.369</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.369</ArticleId><ArticleId IdType="pmc">PMC2705913</ArticleId><ArticleId IdType="pubmed">19363478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mencia A, Modamio-Hoybjor S, Redshaw N, Morin M, Mayo-Merino F, Olavarrieta L, et al. . Mutations in the seed region of human mir-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet (2009) 41(5):609&#x2013;13. doi:&#xa0;10.1038/ng.355</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.355</ArticleId><ArticleId IdType="pubmed">19363479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MA, Buniello A, Hilton JM, Zhu F, Zhang WI, Evans S, et al. . Exploring regulatory networks of mir-96 in the developing inner ear. Sci Rep (2016) 6:23363. doi:&#xa0;10.1038/srep23363</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23363</ArticleId><ArticleId IdType="pmc">PMC4796898</ArticleId><ArticleId IdType="pubmed">26988146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MA, Di Domenico F, Ingham NJ, Prosser HM, Steel KP. Hearing impairment due to Mir183/96/182 mutations suggests both loss and gain of function effects. Dis Model Mech (2020) 14(2). doi:&#xa0;10.1242/dmm.047225</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.047225</ArticleId><ArticleId IdType="pmc">PMC7903918</ArticleId><ArticleId IdType="pubmed">33318051</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng R, Furness DN, Muraleedharan CK, Zhang J, Dabdoub A, Lin V, et al. . The microrna-183/96/182 cluster is essential for stereociliary bundle formation and function of cochlear sensory hair cells. Sci Rep (2018) 8(1):18022. doi:&#xa0;10.1038/s41598-018-36894-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36894-z</ArticleId><ArticleId IdType="pmc">PMC6303392</ArticleId><ArticleId IdType="pubmed">30575790</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumayag S, Haldin CE, Corbett NJ, Wahlin KJ, Cowan C, Turturro S, et al. . Inactivation of the microrna-183/96/182 cluster results in syndromic retinal degeneration. Proc Natl Acad Sci U.S.A. (2013) 110(6):E507&#x2013;16. doi:&#xa0;10.1073/pnas.1212655110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1212655110</ArticleId><ArticleId IdType="pmc">PMC3568372</ArticleId><ArticleId IdType="pubmed">23341629</ArticleId></ArticleIdList></Reference><Reference><Citation>Krol J, Busskamp V, Markiewicz I, Stadler MB, Ribi S, Richter J, et al. . Characterizing light-regulated retinal micrornas reveals rapid turnover as a common property of neuronal micrornas. Cell (2010) 141(4):618&#x2013;31. doi:&#xa0;10.1016/j.cell.2010.03.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.039</ArticleId><ArticleId IdType="pubmed">20478254</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin ZB, Hirokawa G, Gui L, Takahashi R, Osakada F, Hiura Y, et al. . Targeted deletion of mir-182, an abundant retinal microrna. Mol Vis (2009) 15:523&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2654046</ArticleId><ArticleId IdType="pubmed">19279690</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KC, Chen XJ, Jin GH, Wang XY, Yang DD, Li YP, et al. . Deletion of mir-182 leads to retinal dysfunction in mice. Invest Ophthalmol Vis Sci (2019) 60(4):1265&#x2013;74. doi:&#xa0;10.1167/iovs.18-24166</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.18-24166</ArticleId><ArticleId IdType="pubmed">30924851</ArticleId></ArticleIdList></Reference><Reference><Citation>Donatelli SS, Zhou J-M, Gilvary DL, Eksioglu EA, Chen X, Cress WD, et al. . Tgf-B&#x2013;inducible microrna-183 silences tumor-associated natural killer cells. Proc Natl Acad Sci (2014) 111(11):4203&#x2013;8. doi: 10.1073/pnas.1319269111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1319269111</ArticleId><ArticleId IdType="pmc">PMC3964044</ArticleId><ArticleId IdType="pubmed">24586048</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan U, Ghazanfar H. T Lymphocytes and autoimmunity. Int Rev Cell Mol Biol (2018) 341:125&#x2013;68. doi:&#xa0;10.1016/bs.ircmb.2018.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ircmb.2018.05.008</ArticleId><ArticleId IdType="pubmed">30262031</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ger A, Kuchroo VK. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol (2010) 72(3):173&#x2013;84. doi:&#xa0;10.1111/j.1365-3083.2010.02432.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2010.02432.x</ArticleId><ArticleId IdType="pmc">PMC3129000</ArticleId><ArticleId IdType="pubmed">20696013</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel J, Alter C, Luppus S, Eckstein A, Tan S, Fuhrer D, et al. . Microrna-183 and microrna-96 are associated with autoimmune responses by regulating T cell activation. J Autoimmun (2019) 96:94&#x2013;103. doi:&#xa0;10.1016/j.jaut.2018.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.08.010</ArticleId><ArticleId IdType="pubmed">30201436</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan C, Ping CY, Shang XY, Tian JT, Zhao SH, Li L, et al. . Microrna 182 inhibits Cd4(+)Cd25(+)Foxp3(+) treg differentiation in experimental autoimmune encephalomyelitis. Clin Immunol (2016) 173:109&#x2013;16. doi:&#xa0;10.1016/j.clim.2016.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.09.008</ArticleId><ArticleId IdType="pubmed">27664932</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Sun P, Zhang Y, Xu Y, Sun Y. Mir-182-5p inhibits the pathogenic Th17 response in experimental autoimmune uveitis mice Via suppressing Taf15. Biochem Biophys Res Commun (2020) 529(3):784&#x2013;92. doi:&#xa0;10.1016/j.bbrc.2020.06.073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.06.073</ArticleId><ArticleId IdType="pubmed">32736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol (2019) 41(3):283&#x2013;97. doi:&#xa0;10.1007/s00281-019-00733-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-019-00733-8</ArticleId><ArticleId IdType="pubmed">30891627</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung S, Liu X, Fang L, Chen X, Guo T, Zhang J. The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol (2010) 7(3):182&#x2013;9. doi:&#xa0;10.1038/cmi.2010.22</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2010.22</ArticleId><ArticleId IdType="pmc">PMC4002916</ArticleId><ArticleId IdType="pubmed">20383174</ArticleId></ArticleIdList></Reference><Reference><Citation>Monneaux F, Dumortier H, Steiner G, Briand JP, Muller S. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in Mrl/Fas(Lpr) and (Nzb X Nzw)F(1) lupus mice. Int Immunol (2001) 13(9):1155&#x2013;63. doi: 10.1093/intimm/13.9.1155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/13.9.1155</ArticleId><ArticleId IdType="pubmed">11526096</ArticleId></ArticleIdList></Reference><Reference><Citation>Capone A, Volpe E. Transcriptional regulators of T helper 17 cell differentiation in health and autoimmune diseases. Front Immunol (2020) 11:348. doi:&#xa0;10.3389/fimmu.2020.00348</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00348</ArticleId><ArticleId IdType="pmc">PMC7080699</ArticleId><ArticleId IdType="pubmed">32226427</ArticleId></ArticleIdList></Reference><Reference><Citation>Soheilifar MH, Vaseghi H, Seif F, Ariana M, Ghorbanifar S, Habibi N, et al. . Concomitant overexpression of mir-182-5p and mir-182-3p raises the possibility of il-17-Producing treg formation in breast cancer by targeting Cd3d, itk, Foxo1, and nfats: A meta-analysis and experimental study. Cancer Sci (2021) 112(2):589&#x2013;603. doi:&#xa0;10.1111/cas.14764</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.14764</ArticleId><ArticleId IdType="pmc">PMC7893989</ArticleId><ArticleId IdType="pubmed">33283362</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li G, Wu X, Liu Q, Yin C, Brown SL, et al. . Mir-183-96-182 cluster is involved in invariant nkt cell development, maturation, and effector function. J Immunol (2019) 203(12):3256&#x2013;67. doi:&#xa0;10.4049/jimmunol.1900695</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900695</ArticleId><ArticleId IdType="pmc">PMC6986331</ArticleId><ArticleId IdType="pubmed">31748350</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucella JN, Yen WF, Kim MV, van der Veeken J, Luo CT, Socci ND, et al. . Mir-182 is largely dispensable for adaptive immunity: Lack of correlation between expression and function. J Immunol (2015) 194(6):2635&#x2013;42. doi:&#xa0;10.4049/jimmunol.1402261</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1402261</ArticleId><ArticleId IdType="pmc">PMC4355037</ArticleId><ArticleId IdType="pubmed">25672759</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando TR, Rodriguez-Malave NI, Rao DS. Micrornas in b cell development and malignancy. J Hematol Oncol (2012) 5:7. doi:&#xa0;10.1186/1756-8722-5-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-8722-5-7</ArticleId><ArticleId IdType="pmc">PMC3338094</ArticleId><ArticleId IdType="pubmed">22401860</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaway M, Chwat-Edelstein T, Vuong BQ. Regulatory non-coding rnas modulate transcriptional activation during b cell development. Front Genet (2021) 12:678084. doi:&#xa0;10.3389/fgene.2021.678084</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.678084</ArticleId><ArticleId IdType="pmc">PMC8551670</ArticleId><ArticleId IdType="pubmed">34721515</ArticleId></ArticleIdList></Reference><Reference><Citation>de Y&#xe9;benes VG, Bartolom&#xe9;-Izquierdo N, Ramiro AR. Regulation of b-cell development and function by micrornas. Immunol Rev (2013) 253(1):25&#x2013;39. doi:&#xa0;10.1111/imr.12046</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12046</ArticleId><ArticleId IdType="pmc">PMC3686225</ArticleId><ArticleId IdType="pubmed">23550636</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YF, Ou X, Xu S, Jin ZB, Iwai N, Lam KP. Loss of mir-182 affects b-cell extrafollicular antibody response. Immunology (2016) 148(2):140&#x2013;9. doi:&#xa0;10.1111/imm.12592</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12592</ArticleId><ArticleId IdType="pmc">PMC4863571</ArticleId><ArticleId IdType="pubmed">26849109</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucella JN, Cols M, Yen WF, Xu S, Chaudhuri J. The b cell activation-induced mir-183 cluster plays a minimal role in canonical primary humoral responses. J Immunol (Baltimore Md 1950) (2019) 202(5):1383&#x2013;96. doi:&#xa0;10.4049/jimmunol.1800071</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800071</ArticleId><ArticleId IdType="pmc">PMC6986270</ArticleId><ArticleId IdType="pubmed">30683701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tas SW, Quartier P, Botto M, Fossati-Jimack L. Macrophages from patients with sle and rheumatoid arthritis have defective adhesion in vitro, while only sle macrophages have impaired uptake of apoptotic cells. Ann rheumatic Dis (2006) 65(2):216&#x2013;21. doi:&#xa0;10.1136/ard.2005.037143</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2005.037143</ArticleId><ArticleId IdType="pmc">PMC1798004</ArticleId><ArticleId IdType="pubmed">16014673</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis rheumatism (1998) 41(7):1241&#x2013;50. doi:&#xa0;10.1002/1529-0131(199807)41:7&lt;1241</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199807)41:7&lt;1241</ArticleId><ArticleId IdType="pubmed">9663482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamada MM, Jia Y, Wu X. Macrophage polarization and plasticity in systemic lupus erythematosus. Front Immunol (2021) 12:734008. doi:&#xa0;10.3389/fimmu.2021.734008</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.734008</ArticleId><ArticleId IdType="pmc">PMC8721097</ArticleId><ArticleId IdType="pubmed">34987500</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrada AA, Escobedo N, Iruretagoyena M, Valenzuela RA, Burgos PI, Cuitino L, et al. . Innate immune cells' contribution to systemic lupus erythematosus. Front Immunol (2019) 10:772. doi:&#xa0;10.3389/fimmu.2019.00772</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00772</ArticleId><ArticleId IdType="pmc">PMC6476281</ArticleId><ArticleId IdType="pubmed">31037070</ArticleId></ArticleIdList></Reference><Reference><Citation>Coku A, McClellan SA, Van Buren E, Back JB, Hazlett LD, Xu S. The mir-183/96/182 cluster regulates the functions of corneal resident macrophages. ImmunoHorizons (2020) 4(11):729&#x2013;44. doi: 10.4049/immunohorizons.2000091</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2000091</ArticleId><ArticleId IdType="pmc">PMC7891884</ArticleId><ArticleId IdType="pubmed">33208381</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraleedharan CK, McClellan SA, Ekanayaka SA, Francis R, Zmejkoski A, Hazlett LD, et al. . The mir-183/96/182 cluster regulates macrophage functions in response to pseudomonas aeruginosa. J innate Immun (2019) 11(4):347&#x2013;58. doi:&#xa0;10.1159/000495472</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000495472</ArticleId><ArticleId IdType="pmc">PMC6738186</ArticleId><ArticleId IdType="pubmed">30625496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, et al. . Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through mir-182-Regulated macrophage polarization. Cardiovasc Res (2019) 115(7):1205&#x2013;16. doi:&#xa0;10.1093/cvr/cvz040</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvz040</ArticleId><ArticleId IdType="pmc">PMC6529919</ArticleId><ArticleId IdType="pubmed">30753344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong FH, Long L, Yang YS, Shen DH, Zhang YS, Wang XS, et al. . Attenuated macrophage activation mediated by microrna-183 knockdown through targeting Nr4a2. Exp Ther Med (2021) 21(4):300. doi:&#xa0;10.3892/etm.2021.9731</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.9731</ArticleId><ArticleId IdType="pmc">PMC7885059</ArticleId><ArticleId IdType="pubmed">33717243</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman MM, Fawzy IO, Bassiouni AA, Gomaa AI, Esmat G, Waked I, et al. . Enhancing nk cell cytotoxicity by mir-182 in hepatocellular carcinoma. Hum Immunol (2016) 77(8):667&#x2013;73. doi: 10.1016/j.humimm.2016.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2016.04.020</ArticleId><ArticleId IdType="pubmed">27262453</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadallah S, Schmied L, Eken C, Charoudeh HN, Amicarella F, Schifferli JA. Platelet-derived ectosomes reduce nk cell function. J Immunol (Baltimore Md 1950) (2016) 197(5):1663&#x2013;71. doi:&#xa0;10.4049/jimmunol.1502658</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1502658</ArticleId><ArticleId IdType="pubmed">27448586</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory DJ, Kramnik I, Kobzik L. Protection of macrophages from intracellular pathogens by mir-182-5p mimic-a gene expression meta-analysis approach. FEBS J (2018) 285(2):244&#x2013;60. doi:&#xa0;10.1111/febs.14348</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14348</ArticleId><ArticleId IdType="pmc">PMC5845812</ArticleId><ArticleId IdType="pubmed">29197182</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraleedharan CK, McClellan SA, Barrett RP, Li C, Montenegro D, Carion T, et al. . Inactivation of the mir-183/96/182 cluster decreases the severity of pseudomonas aeruginosa-induced keratitis. Invest Ophthalmol Visual Sci (2016) 57(4):1506&#x2013;17. doi: 10.1167/iovs.16-19134</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.16-19134</ArticleId><ArticleId IdType="pmc">PMC4819431</ArticleId><ArticleId IdType="pubmed">27035623</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntington ND, Cursons J, Rautela J. The cancer-natural killer cell immunity cycle. Nat Rev Cancer (2020) 20(8):437&#x2013;54. doi:&#xa0;10.1038/s41568-020-0272-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-020-0272-z</ArticleId><ArticleId IdType="pubmed">32581320</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorkstrom NK, Strunz B, Ljunggren HG. Natural killer cells in antiviral immunity. Nat Rev Immunol (2022) 22(2):112&#x2013;23. doi:&#xa0;10.1038/s41577-021-00558-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00558-3</ArticleId><ArticleId IdType="pmc">PMC8194386</ArticleId><ArticleId IdType="pubmed">34117484</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaki R, Watson SR, Lanier LL. Dap12: An adapter protein with dual functionality. Immunol Rev (2006) 214:118&#x2013;29. doi:&#xa0;10.1111/j.1600-065X.2006.00466.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2006.00466.x</ArticleId><ArticleId IdType="pubmed">17100880</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Heid B, Dai R, Ahmed SA. Similar dysregulation of lupus-associated mirnas in peripheral blood mononuclear cells and splenic lymphocytes in MRL/Lpr mice. Lupus Sci Med (2018) 5(1):e000290. doi:&#xa0;10.1136/lupus-2018-000290</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2018-000290</ArticleId><ArticleId IdType="pmc">PMC6241985</ArticleId><ArticleId IdType="pubmed">30515297</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi EW, Lee M, Song JW, Shin IS, Kim SJ. Mesenchymal stem cell transplantation can restore lupus disease-associated mirna expression and Th1/Th2 ratios in a murine model of sle. Sci Rep (2016) 6:38237. doi:&#xa0;10.1038/srep38237</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep38237</ArticleId><ArticleId IdType="pmc">PMC5141468</ArticleId><ArticleId IdType="pubmed">27924862</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Wang G, Zhang X, Dou Y, Dong Y, Liu D, et al. . Inhibition of microrna-182-5p contributes to attenuation of lupus nephritis via Foxo1 signaling. Exp Cell Res (2018) 373(1-2):91&#x2013;8. doi:&#xa0;10.1016/j.yexcr.2018.09.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.09.026</ArticleId><ArticleId IdType="pubmed">30308195</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JQ, Papp G, Poliska S, Szabo K, Tarr T, Balint BL, et al. . Microrna expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary sjogren's syndrome. PloS One (2017) 12(3):e0174585. doi:&#xa0;10.1371/journal.pone.0174585</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174585</ArticleId><ArticleId IdType="pmc">PMC5365120</ArticleId><ArticleId IdType="pubmed">28339495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Zhang J, Luan P, Ma Z, Dang J, Zhu H, et al. . Mir-183-5p is a potential molecular marker of systemic lupus erythematosus. J Immunol Res (2021) 2021:5547635. doi:&#xa0;10.1155/2021/5547635</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5547635</ArticleId><ArticleId IdType="pmc">PMC8124875</ArticleId><ArticleId IdType="pubmed">34036107</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Luo F, Li J, Luo C. Mir-183 delivery attenuates murine lupus nephritis-related injuries Via targeting mtor. Scand J Immunol (2019) 90(5):e12810. doi:&#xa0;10.1111/sji.12810</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12810</ArticleId><ArticleId IdType="pubmed">31325389</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi H, Cao Q, Liu Q. Microrna-183 exerts a protective role in lupus nephritis through blunting the activation of tgf-Beta/Smad/Tlr3 pathway Via reducing Tgfbr1. Exp Cell Res (2020) 394(2):112138. doi:&#xa0;10.1016/j.yexcr.2020.112138</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.112138</ArticleId><ArticleId IdType="pubmed">32535034</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro-Quiroz E, Pacheco-Lugo L, Lorenzi H, Diaz-Olmos Y, Almendrales L, Rico E, et al. . High-throughput sequencing reveals circulating mirnas as potential biomarkers of kidney damage in patients with systemic lupus erythematosus. PloS One (2016) 11(11):e0166202. doi:&#xa0;10.1371/journal.pone.0166202</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0166202</ArticleId><ArticleId IdType="pmc">PMC5106044</ArticleId><ArticleId IdType="pubmed">27835701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormseth MJ, Solus JF, Sheng Q, Ye F, Wu Q, Guo Y, et al. . Development and validation of a microrna panel to differentiate between patients with rheumatoid arthritis or systemic lupus erythematosus and controls. J Rheumatol (2020) 47(2):188&#x2013;96. doi:&#xa0;10.3899/jrheum.181029</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.181029</ArticleId><ArticleId IdType="pmc">PMC6856415</ArticleId><ArticleId IdType="pubmed">31092710</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhang X, Wang Y. Mir-183-3p suppresses proliferation and migration of keratinocyte in psoriasis by inhibiting Gab1. Hereditas (2020) 157(1):28. doi:&#xa0;10.1186/s41065-020-00138-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41065-020-00138-w</ArticleId><ArticleId IdType="pmc">PMC7353791</ArticleId><ArticleId IdType="pubmed">32650835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu YR, Chang SW, Lin YC, Yang CH. Expression of micrornas in the eyes of Lewis rats with experimental autoimmune anterior uveitis. Mediators Inflammation (2015) 2015:457835. doi:&#xa0;10.1155/2015/457835</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/457835</ArticleId><ArticleId IdType="pmc">PMC4680116</ArticleId><ArticleId IdType="pubmed">26713004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko Y, Wu GS, Saraswathy S, Vasconcelos-Santos DV, Rao NA. Immunopathologic processes in sympathetic ophthalmia as signified by microrna profiling. Invest Ophthalmol Vis Sci (2012) 53(7):4197&#x2013;204. doi:&#xa0;10.1167/iovs.12-9465</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.12-9465</ArticleId><ArticleId IdType="pmc">PMC3392009</ArticleId><ArticleId IdType="pubmed">22589448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishida W, Fukuda K, Higuchi T, Kajisako M, Sakamoto S, Fukushima A. Dynamic changes of micrornas in the eye during the development of experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci (2011) 52(1):611&#x2013;7. doi:&#xa0;10.1167/iovs.10-6115</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.10-6115</ArticleId><ArticleId IdType="pubmed">20881307</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis N. Transforming growth factor-beta in tissue fibrosis. J Exp Med (2020) 217(3):e20190103. doi:&#xa0;10.1084/jem.20190103</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190103</ArticleId><ArticleId IdType="pmc">PMC7062524</ArticleId><ArticleId IdType="pubmed">32997468</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepie&#x144;-Wyrobiec O, Hrycek A, Wyrobiec G. Transforming growth factor beta (Tgf-beta): Its structure, function, and role in the pathogenesis of systemic lupus erythematosus. Postepy Higieny i Medycyny Doswiadczalnej (Online) (2008) 62:688&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">19188884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Tan W, Ji J, Feng G, Meng Y, Da Z, et al. . Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from Mrl/Lpr mice and systemic lupus erythematosus patients through inhibition of the mtor signaling pathway. Aging (Albany NY) (2016) 8(5):1102&#x2013;14. doi:&#xa0;10.18632/aging.100925</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100925</ArticleId><ArticleId IdType="pmc">PMC4931856</ArticleId><ArticleId IdType="pubmed">27048648</ArticleId></ArticleIdList></Reference><Reference><Citation>Suto T, Karonitsch T. The immunobiology of mtor in autoimmunity. J Autoimmun (2020) 110:102373. doi:&#xa0;10.1016/j.jaut.2019.102373</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102373</ArticleId><ArticleId IdType="pubmed">31831256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Li N, Zhao L, Yang C, Ma B, Li X, et al. . Micrornas and autoimmune-mediated eye diseases. Front Cell Dev Biol (2020) 8:818. doi:&#xa0;10.3389/fcell.2020.00818</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00818</ArticleId><ArticleId IdType="pmc">PMC7468483</ArticleId><ArticleId IdType="pubmed">32974350</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Liu Y, Bai L, Kijlstra A, Yang P. Predisposition to behcet's disease and vkh syndrome by genetic variants of mir-182. J Mol Med (Berl) (2014) 92(9):961&#x2013;7. doi:&#xa0;10.1007/s00109-014-1159-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-014-1159-9</ArticleId><ArticleId IdType="pubmed">24801147</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Wu H, Zhao M, Chang C, Lu Q. Clinical significance of mirnas in autoimmunity. J Autoimmun (2020) 109:102438. doi:&#xa0;10.1016/j.jaut.2020.102438</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102438</ArticleId><ArticleId IdType="pubmed">32184036</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann V, Winkler J. Mirna-based therapies: Strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem (2014) 6(17):1967&#x2013;84. doi:&#xa0;10.4155/fmc.14.116</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc.14.116</ArticleId><ArticleId IdType="pmc">PMC4417715</ArticleId><ArticleId IdType="pubmed">25495987</ArticleId></ArticleIdList></Reference><Reference><Citation>Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N. Microrna therapeutics in cancer: Current advances and challenges. Cancers (Basel) (2021) 13(11). doi:&#xa0;10.3390/cancers13112680</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13112680</ArticleId><ArticleId IdType="pmc">PMC8198729</ArticleId><ArticleId IdType="pubmed">34072348</ArticleId></ArticleIdList></Reference><Reference><Citation>Daien C, Krogulec M, Gineste P, Steens JM, Desroys du Roure L, Biguenet S, et al. . Safety and efficacy of the mir-124 upregulator Abx464 (Obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-tnfalpha therapy: A placebo-controlled phase ii study. Ann rheumatic Dis (2022) 81(8):1076&#x2013;84. doi:&#xa0;10.1136/annrheumdis-2022-222228</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2022-222228</ArticleId><ArticleId IdType="pmc">PMC9279835</ArticleId><ArticleId IdType="pubmed">35641124</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeire S, Sands BE, Tilg H, Tulassay Z, Kempinski R, Danese S, et al. . Abx464 (Obefazimod) for moderate-to-Severe, active ulcerative colitis: A phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension. Lancet Gastroenterol Hepatol (2022) 7(11):1024&#x2013;35. doi:&#xa0;10.1016/S2468-1253(22)00233-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(22)00233-3</ArticleId><ArticleId IdType="pubmed">36075249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavez E, Rodriguez J, Drexler Y, Fornoni A. Novel therapies for alport syndrome. Front Med (Lausanne) (2022) 9:848389. doi:&#xa0;10.3389/fmed.2022.848389</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.848389</ArticleId><ArticleId IdType="pmc">PMC9081811</ArticleId><ArticleId IdType="pubmed">35547199</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C, Sharma AR, Sharma G, Lee SS. Therapeutic advances of mirnas: A preclinical and clinical update. J Adv Res (2021) 28:127&#x2013;38. doi:&#xa0;10.1016/j.jare.2020.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2020.08.012</ArticleId><ArticleId IdType="pmc">PMC7753224</ArticleId><ArticleId IdType="pubmed">33364050</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>